Yali Xu
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)Breast Cancer Treatment Studies (6 papers)Estrogen and related hormone effects (5 papers)
- Journals
- PLoS ONECancer ResearchOncogene
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Yali Xu
58 papers receiving 673 citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 371
- Cancer Research 232
- Oncology 208
- Pulmonary and Respiratory Medicine 92
- Pathology and Forensic Medicine 55
Countries citing papers authored by Yali Xu
This map shows the geographic impact of Yali Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Xu more than expected).
Fields of papers citing papers by Yali Xu
This network shows the impact of papers produced by Yali Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Xu. The network helps show where Yali Xu may publish in the future.
Co-authorship network of co-authors of Yali Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yali Xu. A scholar is included among the top collaborators of Yali Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali Xu. Yali Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 6 | |
| 11 | 10 | |
| 12 | 19 | |
| 13 | 25 | |
| 14 | 24 | |
| 15 | 12 | |
| 16 | 24 | |
| 17 | 61 | |
| 18 | 14 | |
| 19 | 2 | |
| 20 | 41 |
About Yali Xu
Yali Xu is a scholar working on Cancer Research, Geriatrics and Gerontology and Oncology, having authored 63 papers that have together received 683 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Cancer Research (232 citations), Oncology (208 citations) and Molecular Biology (371 citations). Yali Xu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Songjie Shen, Yu Song, Yidong Zhou, Bin Zhao, Xinyu Ren, Qiang Sun, Yan Lin, Ying Zhong, Jinghong Guan and Ye Zhang. Their work appears in journals such as PLoS ONE, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.